You need to be investigated for your lies. This is a real company with real products. You my friend are a penny chaser looser...
I said it the other day that I am long GALE but got bashed when I said that the shorts are in complete control. Blockbusting news is the only thing that will cure this diseased stock. Bashing articles support these shorts and it is an endemic problem in the market in general.
Hope is not a strategy, solid news is.
I think this is setting up for a settlement m friends... Kevi drops the appeal and both sides agree to licenses and they live happily ever after. Let's not forget, Kevi is and attorney in his own right so this could get interesting. Thank God they still have clients and a revenue stream...
I don't think any pivotal decisions will be made today unless the judge throws it out, which is likely.
Large volume and a very strong morning but there was no follow-thru buying, no big money support. Just pure manipulation...
But guess what, their time will come and when it does, a lot of these #$%$-balls will loose everything.
Then around 2:30 it starts heading higher. Lunch time doldrums so don't worry, time to buy more under $2.40. we may close around $2.60 today.
The billing person at my family doctor swiped my FSA Mater Card yesterday and within 5 seconds the transaction went thru and I signed her smart phone with my finger. The confirmation of the transaction took less than 15 secs total. I am sold, and they love the back end reporting...
zerosum2013 is really jibjob. They sound (type) too much alike. Caught!
We need sales, end of story!
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.
Analysis? I am waiting for the company statement that says we are reviewing the test and will analyze the review of the test.
Dear Mr Biggar, you are much better saying nothing than publishing these meaningless non-revenue generating comments. Let's get to something substantive please.
Lawsuits (although this is just an investigation so I am not sure why this even made the news) tend to go away with a rise in the share price. GALE will be no exception.
Wouldn't it be so funny if all three Purcell Julie and Lefkowitzsteincohen all get cancer and they were refused the drug... These lawsuits always pan out to nothing but a nuisance settlement by the company's insurer and the law firm makes a million and the share holders get $.45. These law firms are akin to dog p e c k e r flys. Most are nose picking bogger rolling snot eating slobs.
Main thing that the FDA looks at, outside of whether or not the drug works (and we know it does) is safety. This is safe! Long term investors will be paid off, be patient and buy on dips.
The science is owned by them and the judge, although has a hard decision, will side with GERS since he will not let speculation and presumption get in the way of good science and patent issuance.